ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 77 filers reported holding ONCOCYTE CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $55,000 | -19.1% | 75,120 | 0.0% | 0.04% | -18.9% |
| Q2 2022 | $68,000 | -39.3% | 75,120 | 0.0% | 0.05% | -25.4% |
| Q1 2022 | $112,000 | -21.1% | 75,120 | -0.3% | 0.07% | -27.6% |
| Q4 2021 | $142,000 | -34.9% | 75,330 | +13.8% | 0.10% | -36.4% |
| Q3 2021 | $218,000 | -36.8% | 66,200 | +10.3% | 0.15% | -36.9% |
| Q2 2021 | $345,000 | +10.6% | 60,025 | 0.0% | 0.24% | +7.5% |
| Q1 2021 | $312,000 | +280.5% | 60,025 | +74.2% | 0.23% | +183.8% |
| Q4 2020 | $82,000 | – | 34,465 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 23,353,697 | $17,048,000 | 1.30% |
| AWM Investment Company, Inc. | 7,746,557 | $5,655,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 18,056,274 | $13,181,000 | 0.76% |
| Defender Capital, LLC. | 2,551,980 | $1,883,000 | 0.74% |
| Penbrook Management LLC | 563,350 | $411,000 | 0.35% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $241,000 | 0.33% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $55,000 | 0.04% |
| Fort Sheridan Advisors LLC | 135,000 | $99,000 | 0.03% |
| Orbimed Advisors | 1,882,768 | $1,374,000 | 0.03% |
| WEALTH EFFECTS LLC | 51,000 | $37,000 | 0.02% |